• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种产细菌素且假定为益生菌的亚种2a菌株的有益特性和安全性

Beneficial and Safety Properties of a Bacteriocinogenic and Putative Probiotic subsp. 2a Strain.

作者信息

Lipilkina Tatiana Alexandrovna, Xu Cristhian, Barbosa Matheus de Souza, Khramova Valentina Nikolaevna, Shebeko Sergei K, Ermakov Alexey M, Ivanova Iskra Vitanova, Todorov Svetoslav Dimitrov

机构信息

ProBacLab, Laboratório de Microbiologia de Alimentos, Departamento de Alimentos e Nutrição Experimental, Food Research Center, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo 05508-000, Brazil.

Faculty of Bioengineering and Veterinary Medicine, Don State Technical University, Gagarina Sq., 1, Rostov-on-Don 344002, Russia.

出版信息

Foods. 2024 Nov 25;13(23):3770. doi: 10.3390/foods13233770.

DOI:10.3390/foods13233770
PMID:39682842
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11640536/
Abstract

This work aimed to evaluate some of the probiotic features and safety of the bacteriocin-producing subsp. 2a. The effect of selected commercial drugs from different generic groups and antibiotics on the growth of subsp. 2a was also determined. The presence of virulence factors was determined based on PCR with total DNA from subsp. 2a. Good growth of subsp. 2a was recorded in MRS broth supplemented with 0.2% or 0.4% oxbile or in MRS broth adjusted to a pH from 5.0-9.0. Auto-aggregation of subsp. 2a was 62.59%. Different levels of co-aggregation were recorded between subsp. 2a and ATCC19443, ATCC15521 and ScottA. Growth of subsp. 2a was not inhibited by commercial drugs from different generic groups. The inhibitory effect on the growth of subsp. 2a was recorded only in the presence of Arotin [selective serotonin reuptake inhibitor antidepressant] Minimal Inhibition Concentration (MIC) 1.0 mg/mL, Atlansil [Antiarrhythmic] MIC 0.625 mg/mL, Diclofenac potassium [non-steroidal anti-inflammatory drug (NSAID)] MIC 2.5 mg/mL and Spidufen [NSAID] MIC 15.0 mg/mL. Only two antibiotics tested in this study, Amoxil and Urotrobel, inhibited the growth of subsp. 2a with a MIC of <0.5 mg/mL and 5.0 mg/mL, respectively. However, subsp. 2a generated positive PCR results on the DNA level for A (vancomycin resistance), (hyaluronidase), (enterococcal surface protein), (adhesion of collagen) and A (cytolisin) and a high virulence profile when examined for the presence of virulence factors. It is important to underline that cytolysis has been described as a virulence and antibacterial factor.

摘要

本研究旨在评估产细菌素的亚种2a的一些益生菌特性和安全性。还测定了来自不同通用类别的选定商业药物和抗生素对亚种2a生长的影响。基于对亚种2a总DNA进行的PCR检测来确定毒力因子的存在。在添加0.2%或0.4%牛胆汁的MRS肉汤中或pH值调节至5.0 - 9.0的MRS肉汤中,亚种2a生长良好。亚种2a的自聚集率为62.59%。在亚种2a与ATCC19443、ATCC15521和ScottA之间记录到了不同程度的共聚集。来自不同通用类别的商业药物未抑制亚种2a的生长。仅在存在阿罗汀[选择性5-羟色胺再摄取抑制剂抗抑郁药]时记录到对亚种2a生长的抑制作用,其最低抑菌浓度(MIC)为1.0毫克/毫升,阿特兰西尔[抗心律失常药]MIC为0.625毫克/毫升,双氯芬酸钾[非甾体抗炎药(NSAID)]MIC为2.5毫克/毫升,斯皮杜芬[NSAID]MIC为15.0毫克/毫升。本研究中仅测试的两种抗生素,阿莫西林和乌洛托品,分别以<0.5毫克/毫升和5.0毫克/毫升的MIC抑制了亚种2a的生长。然而,当检测毒力因子的存在时,亚种2a在DNA水平上针对A(耐万古霉素)、(透明质酸酶)、(肠球菌表面蛋白)、(胶原黏附)和A(溶细胞素)产生了阳性PCR结果,且具有高毒力特征。需要强调的是,细胞溶解已被描述为一种毒力和抗菌因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6886/11640536/6c8306c0d051/foods-13-03770-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6886/11640536/2d95eaa9c3f2/foods-13-03770-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6886/11640536/6c8306c0d051/foods-13-03770-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6886/11640536/2d95eaa9c3f2/foods-13-03770-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6886/11640536/6c8306c0d051/foods-13-03770-g002.jpg

相似文献

1
Beneficial and Safety Properties of a Bacteriocinogenic and Putative Probiotic subsp. 2a Strain.一种产细菌素且假定为益生菌的亚种2a菌株的有益特性和安全性
Foods. 2024 Nov 25;13(23):3770. doi: 10.3390/foods13233770.
2
Characterization of multiple antilisterial peptides produced by sakacin P-producing Lactobacillus sakei subsp. sakei 2a.产片球菌素P的清酒乳杆菌清酒亚种2a产生的多种抗李斯特菌肽的特性分析
Arch Microbiol. 2018 May;200(4):635-644. doi: 10.1007/s00203-018-1477-3. Epub 2018 Jan 18.
3
Bacteriocin production and inhibition of Listeria monocytogenes by Lactobacillus sakei subsp. sakei 2a in a potentially synbiotic cheese spread.清酒乳杆菌清酒亚种2a在一种潜在的合生元奶酪涂抹酱中产生细菌素并抑制单核细胞增生李斯特菌。
Food Microbiol. 2015 Jun;48:143-52. doi: 10.1016/j.fm.2014.12.010. Epub 2015 Jan 5.
4
Optimization of growth and bacteriocin production by Lactobacillus sakei subsp. sakei2a.清酒乳杆菌清酒亚种sakei2a生长及细菌素产生的优化
Braz J Microbiol. 2015 Jul 1;46(3):825-34. doi: 10.1590/S1517-838246320140279. eCollection 2015 Jul-Sep.
5
Bacteriocin production and resistance to drugs are advantageous features for Lactobacillus acidophilus La-14, a potential probiotic strain.产细菌素和耐药性是嗜酸乳杆菌La-14(一种潜在的益生菌菌株)的有利特性。
New Microbiol. 2011 Oct;34(4):357-70. Epub 2011 Oct 31.
6
Antimicrobial compounds produced by Lactobacillus sakei subsp. sakei 2a, a bacteriocinogenic strain isolated from a Brazilian meat product.由从巴西肉类产品中分离出的具有细菌素生成特性的乳杆菌 sakei 亚种 sakei 2a 产生的抗菌化合物。
J Ind Microbiol Biotechnol. 2010 Apr;37(4):381-90. doi: 10.1007/s10295-009-0684-y.
7
In vitro evaluation of the probiotic potential of bacteriocin producer Lactobacillus sakei 1.体外评估产细菌素乳酸菌 1 的益生菌潜力。
J Food Prot. 2012 Jun;75(6):1083-9. doi: 10.4315/0362-028X.JFP-11-523.
8
Identification and in vitro assessment of potential probiotic characteristics and antibacterial effects of subsp SKI19, a bacteriocinogenic strain isolated from Thai fermented pork sausage.从泰国发酵猪肉香肠中分离出的产细菌素菌株SKI19亚种潜在益生菌特性及抗菌作用的鉴定与体外评估
J Food Sci Technol. 2018 Jul;55(7):2774-2785. doi: 10.1007/s13197-018-3201-3. Epub 2018 Jun 6.
9
Evaluation of metabolic activities and probiotic characteristics of two Latilactobacillus sakei strains isolated from pastırma.从 pastırma 中分离得到的两株清酒乳杆菌的代谢活性和益生菌特性评价。
World J Microbiol Biotechnol. 2022 Oct 16;38(12):237. doi: 10.1007/s11274-022-03431-0.
10
Bacteriocinogenic Lactococcus lactis subsp. lactis DF04Mi isolated from goat milk: evaluation of the probiotic potential.从山羊奶中分离出的产细菌素乳酸乳球菌乳酸亚种DF04Mi:益生菌潜力评估
Braz J Microbiol. 2014 Oct 9;45(3):1047-54. doi: 10.1590/s1517-83822014000300038. eCollection 2014.

引用本文的文献

1
Advancing Nigerian Indigenous Poultry Health and Production, Use of Probiotics as Viable Alternatives to Antibiotics: A Review.推进尼日利亚本土家禽健康与生产:益生菌作为抗生素可行替代品的应用综述
Antibiotics (Basel). 2025 Aug 21;14(8):846. doi: 10.3390/antibiotics14080846.
2
Biofilm-Forming Lactic Acid Bacteria in Sausages: Isolation, Characterization, and Inhibition Using -Based Nanoparticles.香肠中形成生物膜的乳酸菌:基于纳米颗粒的分离、表征及抑制
Antibiotics (Basel). 2025 Jun 22;14(7):637. doi: 10.3390/antibiotics14070637.

本文引用的文献

1
A Comprehensive Overview of Postbiotics with a Special Focus on Discovery Techniques and Clinical Applications.后生元的全面概述:特别关注发现技术与临床应用
Foods. 2024 Sep 17;13(18):2937. doi: 10.3390/foods13182937.
2
Bacteriocinogenic anti-listerial properties and safety assessment of Enterococcus faecium and Lactococcus garvieae strains isolated from Brazilian artisanal cheesemaking environment.从巴西传统干酪制作环境中分离出的屎肠球菌和格氏乳球菌的产细菌素抗李斯特菌特性及其安全性评估。
J Appl Microbiol. 2024 Jul 2;135(7). doi: 10.1093/jambio/lxae159.
3
Evaluation of synbiotic combinations of commercial probiotic strains with different prebiotics in in vitro and ex vivo human gut microcosm model.
评估不同益生元与商业益生菌菌株组合在体外和人体肠道微生物模型中的共生作用。
Arch Microbiol. 2024 Jun 21;206(7):315. doi: 10.1007/s00203-024-04030-3.
4
Probiotics for Aquaculture: Hope, Truth, and Reality.水产养殖用益生菌:希望、真相与现实。
Probiotics Antimicrob Proteins. 2024 Dec;16(6):2007-2020. doi: 10.1007/s12602-024-10290-8. Epub 2024 May 27.
5
Bacteriocins: potentials and prospects in health and agrifood systems.细菌素:健康与农业食品系统中的潜力与前景
Arch Microbiol. 2024 Apr 25;206(5):233. doi: 10.1007/s00203-024-03948-y.
6
The Efficacy of Selected Probiotic Strains and Their Combination to Inhibit the Interaction of Adherent-Invasive (AIEC) with a Co-Culture of Caco-2:HT29-MTX Cells.所选益生菌菌株及其组合对抑制黏附侵袭性大肠杆菌(AIEC)与Caco-2:HT29-MTX细胞共培养物相互作用的功效。
Microorganisms. 2024 Feb 29;12(3):502. doi: 10.3390/microorganisms12030502.
7
Unlocking the Potential of Probiotics: A Comprehensive Review on Research, Production, and Regulation of Probiotics.解锁益生菌的潜力:益生菌研究、生产和监管的综合综述。
Probiotics Antimicrob Proteins. 2024 Oct;16(5):1687-1723. doi: 10.1007/s12602-024-10247-x. Epub 2024 Mar 28.
8
The role of gut microbiota in intestinal disease: from an oxidative stress perspective.肠道微生物群在肠道疾病中的作用:从氧化应激角度探讨
Front Microbiol. 2024 Feb 14;15:1328324. doi: 10.3389/fmicb.2024.1328324. eCollection 2024.
9
Recommendations for the use of standardised abbreviations for the former Lactobacillus genera, reclassified in the year 2020.2020年重新分类的前乳杆菌属标准化缩写的使用建议。
Benef Microbes. 2023 Dec 12;15(1):1-4. doi: 10.1163/18762891-20230114.
10
Beneficial effects of GABA-producing potential probiotic Limosilactobacillus fermentum L18 of human origin on intestinal permeability and human gut microbiota.来源于人的产 GABA 潜能益生菌发酵乳杆菌 L18 对肠道通透性和人类肠道微生物群的有益作用。
Microb Cell Fact. 2023 Dec 12;22(1):256. doi: 10.1186/s12934-023-02264-2.